REVVITY, INC. (RVTY) Risk Factors
Health CareLatest 10-Q filed May 12, 2026Source: SEC EDGAR
WealthWire extracted and classified 26 risk factors from REVVITY, INC.’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Legal & regulatory
8 factorsFinancial
7 factorsTechnology
4 factorsMarket & business
4 factorsOperations & people
3 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that REVVITY, INC. surfaced in its latest filing.
- Recent acquisition of Advanced Chemistry Development Inc.
- Recently announced decision to divest Immunodiagnostics business in China
- As of April 5, 2026, total assets included $8.9 billion of net intangible assetsApril 5, 2026
- Tariffs implemented during fiscal year 2025 increased cost of revenue by approximately $25 million and reduced gross margin by approximately $20 million, primarily affecting products manufactured in Europe for the U.S. market.fiscal year 2025
- Senior unsecured revolving credit facility entered into in January 2025, with restrictive covenants and financial ratio requirementsJanuary 2025
- On January 26, 2026, the Board declared a quarterly dividend of $0.07 per share for Q1 FY2026, paid in May 2026January 26, 2026
- On April 30, 2026, the Board declared a quarterly dividend of $0.07 per share for Q2 FY2026, payable in August 2026April 30, 2026
Go deeper on RVTY
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for RVTY and every other S&P 500 company.